Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Value of Antibodies Against Carbamylated Proteins in Psoriatic Arthritis.

NCT04173039 is registered in ClinicalTrials.gov with Association pour la Recherche Clinique et Immunologique as lead sponsor.

NCT NCT04173039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04173039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Value of Antibodies Against Carbamylated Proteins in Psoriatic Arthritis.
Lead sponsor
Association pour la Recherche Clinique et Immunologique
Phase
Not applicable
Overall status
Completed
Start date
August 29, 2018
Completion date
April 24, 2019
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, psoriatic, psoriasis